FDA to unveil guidance for follow-on biologics this year

05/9/2011 | Reuters · Hill, The

The FDA likely will release this year a set of guidelines for drugmakers applying for market approval of follow-on biologics, said Janet Woodcock, head of the agency's Center for Drug Evaluation and Research. The FDA is "meeting with companies individually right now and giving them advice on their programs," and the agency is "very interested in providing competition where we have a mandate," Woodcock said. Separately, the FDA is seeking feedback on a proposal to charge a fee before a generic biotech medicine is reviewed.

View Full Article in:

Reuters · Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC